Transurethral Resection (TUR) Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Transurethral Resection (TUR) Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Transurethral Resection (TUR) Syndrome trials you may qualify forPatients with longstanding obstructive lower urinary tract symptoms (LUTS) due to benign prostatic hypertrophy (BPH) can also develop symptoms of overactive bla…
This study is a prospective, randomized, multicenter clinical trial aiming to enroll 428 patients with non-muscle-invasive bladder cancer (NMIBC) from the Depar…
The goal of this clinical trial is to evaluate the efficacy of using a urine biomarker test to guide the decision-making process regarding the necessity of reTU…
Aim of the study is to compare prostate artery embolization (PAE) to the established surgical treatment for patient acceptance, morbidity, complications, and th…
Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the a…
The aim of this study is to compare between accuracy of lung US and IVC CI for early prediction of volume overload during TURP. Primary outcome: The incidence…